Robert E. Mosser

Array ( [id] => 8483915 [patent_doc_number] => 20120283323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'Treating Learning Deficits with Inhibitors of HMG CoA Reductase' [patent_app_type] => utility [patent_app_number] => 13/517773 [patent_app_country] => US [patent_app_date] => 2012-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21556 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13517773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8516831 [patent_doc_number] => 20120316239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'METHOD FOR PREPARING PERSONAL CARE COMPOSITION COMPRISING MONOALKYL AMINE DUAL SURFACTANT SYSTEM AND SOLUBLE SALT' [patent_app_type] => utility [patent_app_number] => 13/492173 [patent_app_country] => US [patent_app_date] => 2012-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8392 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13492173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11762244 [patent_doc_number] => 09370535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-21 [patent_title] => 'Method for treatment of advanced solid tumors' [patent_app_type] => utility [patent_app_number] => 13/467147 [patent_app_country] => US [patent_app_date] => 2012-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3649 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8779647 [patent_doc_number] => 20130101622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'IMIDAZOQUINOXALINE COMPOUNDS AS IMMUNOMODULATORS' [patent_app_type] => utility [patent_app_number] => 13/466021 [patent_app_country] => US [patent_app_date] => 2012-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 33295 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13466021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382314 [patent_doc_number] => 20120225942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'Synergistic Antimicrobial Agents' [patent_app_type] => utility [patent_app_number] => 13/465489 [patent_app_country] => US [patent_app_date] => 2012-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4129 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8955469 [patent_doc_number] => 08501238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Anti-infective agents and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/451889 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 23 [patent_no_of_words] => 88636 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13451889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453801 [patent_doc_number] => 20120264744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/448737 [patent_app_country] => US [patent_app_date] => 2012-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 38223 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9936936 [patent_doc_number] => 08986740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Anti-infective agents and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/441528 [patent_app_country] => US [patent_app_date] => 2012-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 65535 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13441528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312651 [patent_doc_number] => 20120189672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'USE OF AEROSOLIZED CYCLOSPORINE FOR PREVENTION AND TREATMENT OF PULMONARY DISEASE' [patent_app_type] => utility [patent_app_number] => 13/439187 [patent_app_country] => US [patent_app_date] => 2012-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9770 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8708562 [patent_doc_number] => 20130065850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'TREATMENT OF VIRAL INFECTIONS BY MODULATION OF HOST CELL METABOLIC PATHWAYS' [patent_app_type] => utility [patent_app_number] => 13/438616 [patent_app_country] => US [patent_app_date] => 2012-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 90756 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13438616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278497 [patent_doc_number] => 20120172364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'RATE-CONTROLLED PARTICLES' [patent_app_type] => utility [patent_app_number] => 13/420013 [patent_app_country] => US [patent_app_date] => 2012-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4781 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13420013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301961 [patent_doc_number] => 20120184519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Compositions and Methods for Preventing or Treating Influenza Virus Infection' [patent_app_type] => utility [patent_app_number] => 13/418045 [patent_app_country] => US [patent_app_date] => 2012-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26183 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13418045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10000406 [patent_doc_number] => 09044480 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-06-02 [patent_title] => 'Compositions and methods for treating HCV' [patent_app_type] => utility [patent_app_number] => 13/412167 [patent_app_country] => US [patent_app_date] => 2012-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12137 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932735 [patent_doc_number] => 08492434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Antiviral drugs for treatment of arenavirus infection' [patent_app_type] => utility [patent_app_number] => 13/402167 [patent_app_country] => US [patent_app_date] => 2012-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13170 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13402167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10169219 [patent_doc_number] => 09199920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Antiviral drugs for treatment of arenavirus infection' [patent_app_type] => utility [patent_app_number] => 13/402125 [patent_app_country] => US [patent_app_date] => 2012-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12752 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13402125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15571375 [patent_doc_number] => 10576045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-03 [patent_title] => Low dosage combinations of fluoxetine and reboxetine for treating obesity [patent_app_type] => utility [patent_app_number] => 14/378418 [patent_app_country] => US [patent_app_date] => 2012-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5162 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14378418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347913 [patent_doc_number] => 20120208836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/396320 [patent_app_country] => US [patent_app_date] => 2012-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 14506 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13396320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192069 [patent_doc_number] => 20130331384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'FIRMOCIDIN, AN ANTIMICROBIAL MOLECULE PRODUCED BY STAPHYLOCOCCUS EPIDERMIDIS' [patent_app_type] => utility [patent_app_number] => 13/985548 [patent_app_country] => US [patent_app_date] => 2012-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22424 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9198862 [patent_doc_number] => 20130338178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'SIRTUIN MODULATORS AS INHIBITORS OF CYTOMEGALOVIRUS' [patent_app_type] => utility [patent_app_number] => 13/982779 [patent_app_country] => US [patent_app_date] => 2012-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18242 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9589373 [patent_doc_number] => 08778913 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Antimicrobial compositions for treating microbial infections' [patent_app_type] => utility [patent_app_number] => 13/364082 [patent_app_country] => US [patent_app_date] => 2012-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 19996 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13364082 [rel_patent_id] =>[rel_patent_doc_number] =>)